Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Icu Medical (ICUI) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Icu Medical (ICUI) over the last 17 years, with Q3 2025 value amounting to $27.6 million.

  • Icu Medical's Free Cash Flow rose 7069.25% to $27.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $72.0 million, marking a year-over-year decrease of 5763.98%. This contributed to the annual value of $124.7 million for FY2024, which is 5145.55% up from last year.
  • Per Icu Medical's latest filing, its Free Cash Flow stood at $27.6 million for Q3 2025, which was up 7069.25% from -$8.5 million recorded in Q2 2025.
  • Over the past 5 years, Icu Medical's Free Cash Flow peaked at $62.5 million during Q2 2024, and registered a low of -$85.8 million during Q2 2022.
  • Over the past 5 years, Icu Medical's median Free Cash Flow value was $27.0 million (recorded in 2023), while the average stood at $16.3 million.
  • Its Free Cash Flow has fluctuated over the past 5 years, first crashed by 31950.02% in 2022, then skyrocketed by 41625.67% in 2024.
  • Icu Medical's Free Cash Flow (Quarter) stood at $60.5 million in 2021, then tumbled by 138.5% to -$23.3 million in 2022, then skyrocketed by 363.15% to $61.3 million in 2023, then crashed by 73.73% to $16.1 million in 2024, then skyrocketed by 71.5% to $27.6 million in 2025.
  • Its last three reported values are $27.6 million in Q3 2025, -$8.5 million for Q2 2025, and $36.7 million during Q1 2025.